Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
03-2005 | 12-2004 | 09-2004 | 06-2004 | 03-2004 | |
Assets | |||||
Current Assets | |||||
Cash & Cash Equivalents | 333,385 | 298,653 | 595,219 | 473,399 | 449,937 |
Marketable Securities | 383,142 | 381,679 | 13,578 | 19,475 | 18,966 |
Receivables | 230,024 | 251,459 | 230,102 | 210,619 | 214,176 |
Inventories | 314,778 | 321,299 | 340,147 | 385,119 | 395,788 |
Income taxes - deferred | 84,186 | 90,202 | 96,737 | 97,291 | 105,171 |
TOTAL | $1,367,744 | $1,370,186 | $1,305,077 | $1,229,819 | $1,220,796 |
Non-Current Assets | |||||
PPE Net | 428,084 | 427,377 | 433,031 | 447,820 | 435,943 |
Investments And Advances | 44,818 | 41,299 | 46,353 | 51,189 | 44,028 |
Intangibles | 1,327,728 | 1,368,341 | 1,364,184 | 1,426,602 | 1,439,116 |
Other Non-Current Assets | 29,902 | 30,280 | 22,042 | 26,379 | 26,768 |
TOTAL | $1,830,532 | $1,867,297 | $1,865,610 | $1,951,990 | $1,945,855 |
Total Assets | $3,198,276 | $3,237,483 | $3,170,687 | $3,181,809 | $3,166,651 |
Liabilities | |||||
Current Liabilities | |||||
Accounts payable and accrued liabilities | 181,475 | 192,701 | 179,705 | 210,673 | 209,576 |
TOTAL | $240,434 | $255,629 | $249,224 | $261,273 | $257,562 |
Non-Current Liabilities | |||||
Long Term Debt | 587,724 | 587,653 | 587,583 | 587,511 | 621,027 |
Deferred Revenues | 3,975 | 5,077 | 7,029 | 4,399 | 7,592 |
aiOther Non-Current Liabilities | 4,167 | 4,736 | 5,815 | 6,487 | 9,416 |
TOTAL | $736,587 | $744,905 | $739,223 | $754,291 | $789,328 |
Total Liabilities | $977,021 | $1,000,534 | $988,447 | $1,015,564 | $1,046,890 |
Shareholders' Equity | |||||
Shares Outstanding, K | 110,168 | 110,011 | 109,502 | 109,452 | 108,869 |
Common Shares | 363 | 362 | 361 | 361 | 359 |
Retained earnings | 1,391,958 | 1,346,867 | 1,297,941 | 1,283,296 | 1,248,373 |
Other shareholders' equity | 7,266 | 9,518 | 10,655 | 13,068 | 13,507 |
TOTAL | $2,221,255 | $2,236,949 | $2,182,240 | $2,166,245 | $2,119,761 |
Total Liabilities And Equity | $3,198,276 | $3,237,483 | $3,170,687 | $3,181,809 | $3,166,651 |